newsfilter
← Latest News
Business Wire·

Forma Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other rare hematologic diseases and cancers, today announced that its Board of Directors granted to Agustín